Identification of DNA primase inhibitors via a combined fragment-based and virtual screening

Stefan Ilic, Sabine R. Akabayov, Haribabu Arthanari, Gerhard Wagner, Charles C. Richardson, Barak Akabayov

Research output: Contribution to journalArticlepeer-review


The structural differences between bacterial and human primases render the former an excellent target for drug design. Here we describe a technique for selecting small molecule inhibitors of the activity of T7 DNA primase, an ideal model for bacterial primases due to their common structural and functional features. Using NMR screening, fragment molecules that bind T7 primase were identified and then exploited in virtual filtration to select larger molecules from the ZINC database. The molecules were docked to the primase active site using the available primase crystal structure and ranked based on their predicted binding energies to identify the best candidates for functional and structural investigations. Biochemical assays revealed that some of the molecules inhibit T7 primase-dependent DNA replication. The binding mechanism was delineated via NMR spectroscopy. Our approach, which combines fragment based and virtual screening, is rapid and cost effective and can be applied to other targets.

Original languageEnglish
Article number36322
JournalScientific Reports
StatePublished - 2 Nov 2016

All Science Journal Classification (ASJC) codes

  • General


Dive into the research topics of 'Identification of DNA primase inhibitors via a combined fragment-based and virtual screening'. Together they form a unique fingerprint.

Cite this